FC-004

N/A

Report date: 2025/05/13 14:55:13

Base Information

Drug NameFC-004

Drug Alias NameFC004FC-004

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionMesothelin modulators

TargetsMesothelin

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCancer Center Of Sun Yat Sen University

China Registration ClassN/A

Develop Information

Active CompaniesCancer Center Of Sun Yat Sen University

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A